![Quiver Logo](/static/img/logo-icon.png)
![RMD logo](https://quiver-logos.s3.us-east-2.amazonaws.com/rmd.png)
ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view RMD Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
$RMD is featured in our Tom Carper strategy.
See All StrategiesRecent trades of RMD by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RMD's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to RMD
Recent picks made for RMD stock on CNBC
ETFs with the largest estimated holdings in RMD
Flights by private jets registered to RMD
![Quiver Logo](/static/img/logo-icon.png)